Veeva Systems Inc. with ticker code (VEEV) now have 24 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $270.00 and $200.00 suggesting an average analyst share price target price of $241.47. (at the time of writing). Given that the stocks previous close was at $227.75 this indicates there is a potential upside of 6.0%. The day 50 moving average is $211.67 and the 200 day MA is $198.66. The market cap for the company is 37.20B. The stock price is currently at: $231.05 USD
The potential market cap would be $39,443,896,434 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 71.98, revenue per share of $14.72 and a 5.01% return on assets.
Veeva Systems Inc. is a provider of industry cloud solutions for the global life sciences industry. The Company’s offerings span cloud software, data, and business consulting and are designed to meet the needs of its customers and their most strategic business functions from research and development (R&D) to commercialization. The Company’s industry cloud solutions for the life sciences industry are grouped into two major product families: Veeva Development Cloud and Veeva Commercial Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its proprietary Veeva Vault platform. Veeva Commercial Cloud includes solutions for the sales, medical affairs, and marketing functions of a life sciences company. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.
